Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

The laser comb did not improve hair regrowth in mice with alopecia areata.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Temporary ROS production in cultured human hair follicles promotes growth and stem cell activation.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Tretinoin boosts minoxidil's effect on hair loss by increasing enzyme activity.

Low-dose oral minoxidil for hair loss can cause mild excessive hair growth, usually appearing within the first 3 months, but it can be managed by adjusting the dose or removing the unwanted hair, with most people not needing to stop the treatment.

The medication lopinavir-ritonavir may cause severe hair loss.

Vascular Surgery should become an independent discipline with its own board for a better future.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Topical booster improves hair loss treatment effectiveness.

Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.

Alopecia areata affects quality of life more in adolescents than adults.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.